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a b s t r a c t
Coronary artery perforation fortunately represents a rare complication of coronary cathe-
terization but, if not properly and promptly treated, it is burdened by a high mortality rate.
Rates of coronary perforation may be potentially higher when atherectomy devices are used
or very complex calciﬁed lesions are treated. Cardiac tamponade constitutes the most severe
clinical consequence.
We report the case of an intra-stent coronary perforation at the end of revascularization
of a non-ST elevation myocardial infarction (NSTEMI), followed by an immediate im-
pairment of hemodynamic compensation, due to signiﬁcant pericardial effusion and sub-
sequent cardiac tamponade.
The use of covered stents has revolutionized the management of coronary perforation
and this has meant that the use of emergency CABG has decreased over the years with
satisfactory immediate and short-term outcomes, reducing the incidence of acute cardiac
tamponade and mortality without surgery.
# 2015 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights
reserved.
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.Introduction
Percutaneous coronary intervention (PCI) is today the gold
standard for treatment of coronary lesions, however the
possible complications deserve proper attention and treat-
ment modality. Coronary perforation represents fortunately a* Corresponding author at  : U.O.C. di Cardiologia II con Emodinamica, V       
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burdened by a high mortality rate if not properly and promptly
treated [1,2].
We report the case of an intra-stent coronary perforation at
the end of revascularization of a non-ST elevation myocardial
infarction (NSTEMI), followed by immediate impairment of
hemodynamic compensation due to signiﬁcant pericardial
effusion and subsequent cardiac tamponade.ia Del Vespro, 127, CAP 90127 Palermo, Italy. Tel.: +39 0916554303;          
vier Sp. z o.o. All rights reserved..
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We present the case of a 67-year-old Caucasian man with
arterial hypertension, and also a former smoker, who in 2008
was admitted to our department for lateral NSTEMI. A
coronary angiography was performed in our catheterization
laboratory with the evidence of critical stenosis (70–90%) of the
distal left anterior descending (LAD) coronary artery, which
also appeared dilated with a sequence of moderate stenosis at
the middle segment. An occlusion of the distal left circumﬂex
artery (LCX) was also present rehabilitated by collateral
homocoronaric circulation and moderate stenosis of the right
coronary artery (RCA).
After an ineffective attempt at revascularization of the
distal LCX, the patient was discharged after medical therapy
optimization (aspirin, beta-blocker, ACE inhibitor, statin,
ranitidine).
Due to the persistent unstable angina, a myocardial
scintigraphy was performed in January 2013 which showed
moderate/severe inducible ischemia with low workload
involving the inferolateral myocardial wall. The patient
refused a further coronary angiography.
In November 2013 he was referred to our emergency room
because of the onset of localized pain in the left shoulder. A
diagnosis of NSTEMI was made (ST segment depression in the
anterior side extended max 3 mm in V3-5, ST segment
elevation max 1 mm in aVR) (Fig. 1) and he was transferred
to our cardiology care unit (CCU).
At admission Troponin I was 0.035 ng/ml (normal value
<0.012 ng/ml), eGFR (MDRD) 65.4 ml/min/1.73 mq, Killip class 1
and high GRACE risk score (153).
The patient was treated with acetylsalicylic acid (300 mg
orally) and subcutaneous enoxaparin (6000 IU); an urgent
coronary angiography with right femoral artery access was
performed showing extremely calciﬁed coronary vessels, andFig. 1 – ECG at thcritical stenosis of middle LAD with occluded apical segment
rehabilitated by collateral homocoronaric circulation (Fig. 2,
panels A and B). Distal LCX and obtuse marginal (OMB) were
occluded and rehabilitated by homocoronaric collateral
circulation (Fig. 2, panel C), a RCA with critical stenosis along
its posterolateral and posterior interventricular branches of
small caliber (Fig. 2, panel D).
So we decided to administer prasugrel 60 mg orally and to
perform PCI on middle LAD beyond the critical and extremely
calciﬁed stenosis with the guide wire BMW ABBOTT (a second
ABBOTT BMW guide wire placed on diagonal branch) and with
implantation of a bare metal stent (BMS) MULTI-LINK ABBOTT
5 mm  18 mm (issued to 16 atm, estimated stent diameter
5.33 mm).
At the end of ﬁrst BMS implantation, we observed an aspect
of minus in the stenosis downstream to the distal edge (plaque
shift, stenosis accentuation?), so we proceeded to implanta-
tion of an overlapping BMS MULTI-LINK ABBOTT
4.5 mm  18 mm (issued to 14 atm, diameter reached
4.8 mm) and post-expending the point of overlap with the
balloon of the second stent. Angiography performed after
implantation of these two overlapping BMS showed the
presence of intra-stent coronaric perforation type III [1] with
hemorrhage (Fig. 3, panels A and B) and progressive and rapid
reduction in blood pressure and bradycardia. Due to rapid
hemodynamic destabilization, after the placement of an intra-
aortic balloon pump (IABP), a covered stent GRAFTMASTER
(Jostent Graftmaster, Abbott Vascular) 4.5 mm  16 mm (in-
ﬂated up to cover the perforation) was placed (Fig. 4) but the
angiographic acquisitions in the course of the placement of the
covered stent and at the end of the placement revealed
multiple perforations (difﬁcult to assess precisely because of
severe hypotension, systolic blood pressure 60 mmHg) with
slow ﬂow in the middle-distal segment of LAD (Fig. 5). For this
reason we proceeded to the positioning of an overlapping
covered stent GRAFTMASTER 4.5 mm  19 mm. A subsequente admission.
Fig. 2 – Panels A and B: Coronary angiography showing extremely calcified coronary vessels, critical stenosis of middle LAD
with occluded apical segment rehabilitated by collateral homocoronaric circulation. Panel C: Distal left circumflex artery and
obtuse marginal occluded and rehabilitated by homocoronaric collateral circulation. Paned D: Right coronary artery with
critical stenosis along its posterolateral and posterior interventricular branches of small caliber.
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segments of the LAD (Fig. 6).
Meanwhile, because of cardiac tamponade conﬁrmed by
echocardiography (38 mm pericardial effusion with collapse of
the right cavities), pericardiocentesis was performed (sub-
xiphoid approach) with aspiration of 350 ml of blood and rapid
improvement in hemodynamic balance (normalization of
pressure and cardiac frequency). The IABP and the pericardial
drainage were removed when the patient was stabilized (after
24 h, without further bleeding).The series of ECG performed until discharge showed
resolution of ST-segment depression; there was also a
normalization of myocardial necrosis indices (Fig. 7). Echocar-
diography monitoring (post-pericardiocentesis) showed a
normal size and contractility of left ventricle, and also ejection
fraction at 50%, with no residual pericardial effusion.
The patient was discharged after ﬁve days of the procedure
in dual antiplatelet therapy (prasugrel and acetylsalicylic acid)
and at a follow-up performed after one month, he was in good
clinical condition.
Fig. 3 – Panels A and B: Angiographic acquisitions performed after implantation of two overlapping BMS showing the
presence of intra-stent coronaric perforation type III with hemorrhage.
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Coronary perforation is a potentially lethal although rare
complication of PCI and its rates may be potentially higherFig. 4 – Angiographic acquisition performed after
implantation of the first covered stent GRAFTMASTER
(Jostent Graftmaster, Abbott Vascular) 4.5 mm T 16 mm
(inflated up to cover the perforation).when atherectomy devices are used or if very complex
calciﬁed lesion is treated [3].
The sudden accumulation of blood in the pericardial space
may lead to cardiac tamponade with resulting cardiogenic
shock and high mortality rate. Closure of the perforatedFig. 5 – Angiographic acquisition after positioning of the first
covered stent that shows multiple perforations with slow
flow in the middle-distal segment of LAD.
Fig. 6 – Angiographic acquisition after positioning of an
overlapping covered stent GRAFTMASTER
4.5 mm T 19 mm showing an adequate control of the
perforated segments of the LAD.
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events that could be fatal for the patient [4].
According to the Ellis classiﬁcation, coronary perforations
are classiﬁed as types I (extraluminal crater), II (myocardial or
pericardial blushing), and III (contrast streaming or cavity
spilling). Our case report appears to be a case of type III
coronary artery perforation [1].Fig. 7 – ECG performed before discharge showThe management options of this complication should
include: discontinuing glycoprotein IIb/IIIa inhibitors, heparin
substitution with administration of protamine, prolonged
balloon inﬂation across the dissection in the coronary vessel,
coil embolization, placement of covered stents and surgical
repair [5] (Fig. 8).
Prolonged balloon inﬂation, although is a therapeutic
choice, may result in intra-coronary thrombosis, myocardial
infarction and death [6].
Several devices have been introduced to repair the coronary
perforations and the one we used is the GraftMaster stent [6,7],
a device indicated for use in the treatment of free perforations.
This covered stent, constructed using a sandwich technique,
consists of a biocompatible and expandable polytetraﬂuor-
oethylene layer sandwiched in between two coaxial stainless
steel stents, which are then pre-mounted on a balloon catheter
delivery system.
Although in a type III coronary perforation with hemody-
namic compromise the CABG emergency intervention may be
indicated, due to the elevated risk of this complication and to
the speed of its evolution [8], the time needed to prepare the
operating room might be too long.
In this case, the placing of a graftmaster stent has allowed
us to keep the patient alive thanks to a rapid correction of the
hemorrhage, giving us the time to perform pericardiocentesis
and to solve the cardiac tamponade with an immediate
recovery, an efﬁcient ventricular contractility and a good
hemodynamic compensation. The IABP placement was also
possible despite the presence of abdominal aorta aneurysm
(AAA) under the kidney.
So, although CABG is an excellent treatment in type III Ellis
perforation, the use of covered stents represented an alterna-
tive and quicker treatment. Experience about the use of
covered stents may provide an option to save valuable time for
this serious complication [9], therefore (as reported bying resolution of ST-segment depression.
Fig. 8 – Management of coronary artery perforation.
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used as an alternative treatment when coated stent and the
pericardial drainage had not corrected the initial hemody-
namic compromise [3].
As regard to long-term complications, especially in type III
coronaric perforation, a high incidence rate of these complica-
tions has been shown; Rasha et al., in a retrospective study of
24,465 patients undergoing percutaneous coronary interven-
tion, have reported in 56 patients with type III coronary
perforation a mortality rate of 3.6% [10].
Therefore our case report offers the following different
points of reﬂection: faced with an acute and life-threatening
type III coronary perforation, what to do? Listed therapeutic
options are: prolonged balloon inﬂation, coated stent implan-
tation, CABG surgical repair and embolization [11,12].
However there are various points to consider; ﬁrst of all the
type of injury that we have to face. Although appropriate
management would appear to include the immediate
placement of a perfusion balloon (if longer period available,
balloon should be placed rapidly) to minimize myocardial
ischemia (since some perforations can be ‘‘sealed’’) [1], a
highly calciﬁed coronary segment often does not allow to
recross the lesion and the perforated segment of the stent
with the balloon (used and frayed) and to make a prolonged
balloon inﬂation; so in this case we had to discard this
hypothesis and we place a covered stent (it was easy by the
high caliber of the LAD).
We dropped the surgical option because of severe hemo-
dynamic instability of the patient and because there was noenough time (even if there is, due to the low pressure it was
difﬁcult to have an adequate visualization of the involved
segment to understand if the extravasation of blood had
stopped after covering the overlapping implantation stent).
Resolving the coronary perforation, pericardiocentesis
helped to restore the hemodynamic stability and ventricular
contractility.
According to the literature regarding the type III Ellis
perforations, we have not stopped dual antiplatelet therapy
once the perforation was resolved [1].
Conclusions
We have described the case of a coronary stenosis perforation
in a subject with acute coronary syndrome; a potentially fatal
complication which in our case was successfully treated with
the use of two covered stents without having to resort to
surgery by CABG. The use of covered stents has meant that the
use of emergency CABG has decreased over the years [13].
The use of covered stents for the endovascular repair of
coronary iatrogenic injuries shows a high technical success,
may be a valid alternative to surgery and can achieve favorable
long-term results [14].
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